![Matthew Killeen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Killeen
Direttore Tecnico/Scientifico/R&S presso
RENOVACOR, INC.
Profilo
Matthew Killeen is currently the Director at Sudden Cardiac Arrest Foundation, Advisor-Scientific Affairs at CREAGRI, Inc., and Chief Scientific Officer at Renovacor, Inc. He previously worked as the Head-Cardiovascular Research at BioMarin Pharmaceutical, Inc. and as a Principal at Eli Lilly & Co. Ltd. Killeen holds a doctorate degree from the University of Cambridge and an undergraduate degree from the University of Leeds.
Posizioni attive di Matthew Killeen
| Società | Posizione | Inizio |
|---|---|---|
| RENOVACOR, INC. | Direttore Tecnico/Scientifico/R&S | 01/09/2021 |
CREAGRI, Inc.
 CREAGRI, Inc. Food RetailRetail Trade Develops and supplies antioxidant polyphenols | Corporate Officer/Principal | 12/05/2011 |
Sudden Cardiac Arrest Foundation
 Sudden Cardiac Arrest Foundation Miscellaneous Commercial ServicesCommercial Services Sudden Cardiac Arrest Foundation is a national community benefit organization that aims to eliminate preventable death and disability from sudden cardiac arrest. The company supports individuals affected by SCA and raise awareness through education, research, and community initiatives. The company is located in the US. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Matthew Killeen
| Società | Posizione | Fine |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Direttore Tecnico/Scientifico/R&S | - |
Eli Lilly & Co. Ltd.
 Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical health care solutions | Corporate Officer/Principal | - |
Formazione di Matthew Killeen
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
6
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Leeds
 University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eli Lilly & Co. Ltd.
Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical health care solutions | Health Technology |
CREAGRI, Inc.
CREAGRI, Inc. Food RetailRetail Trade Develops and supplies antioxidant polyphenols | Retail Trade |
Renovacor, Inc.
 Renovacor, Inc. BiotechnologyHealth Technology Engages in research and development for precision gene therapies and genetically driven cardiovascular diseases | Health Technology |
Sudden Cardiac Arrest Foundation
Sudden Cardiac Arrest Foundation Miscellaneous Commercial ServicesCommercial Services Sudden Cardiac Arrest Foundation is a national community benefit organization that aims to eliminate preventable death and disability from sudden cardiac arrest. The company supports individuals affected by SCA and raise awareness through education, research, and community initiatives. The company is located in the US. | Commercial Services |
